Skip to main content
Clinical Trials/NCT01785966
NCT01785966CompletedNot Applicable

Checklist During Multidisciplinary Daily Visits and Clinician Prompting for Reduction of Mortality in Intensive Care Units: A Cluster Randomized Trial

Hospital do Coracao1 site in 1 country13,637 target enrollmentStarted: August 1, 2013Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
13,637
Locations
1
Primary Endpoint
In-hospital mortality truncated at 60 days

Study Overview

Brief Summary

CHECKLIST-ICU will be a cluster randomized trial to ascertain whether the use of an intervention including 1) checklists with assessment of daily goals during the multidisciplinary visit, and 2) clinician prompting can reduce in-hospital mortality of patients admitted to intensive care units (ICUs).

The investigators also aim to describe participant ICUs in terms of the standards for intensive care units proposed by the Brazilian National Health Agency (ANVISA).

Detailed Description

Cluster randomized trial involving ICUs in Brazil. ICU is the unit of randomization.

The trial will have two stages:

  • Stage I - Baseline data.In this stage we will:

  • Apply "Safety Attitudes Questionnaire" for the employees of the participating ICU.

  • Characterize participant ICUs in terms of the standards (RDC nº7/2010, RDC nº26/2012 e RDC nº 63/2011) for intensive care units proposed by the Brazilian National Health Agency (ANVISA)

  • Characterize patients: we will collect data from 60 consecutive critically ill patients from each participant ICU to describe adherence to measures aimed at avoiding ICU complications and clinical outcome measures.

  • Stage II - Intervention: This is the main stage for data analysis. ICUs will be randomly assigned to an experimental or control group. The experimental group should use a multi-item verbal checklist including assessment of daily goals during the multidisciplinary visits plus clinician prompting. We will collect data from 60 additional patients for each ICU in both study groups and apply "Safety Attitudes Questionnaire".

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •for clusters:
  • •Intensive care units, except dedicated coronary care units/cardiac intensive care units and step-down units;
  • •Must have multidisciplinary daily rounds or coordinators agree to implement daily rounds, including at least one physician and one nurse, conducted at least on week days.

Exclusion Criteria

  • •for clusters:
  • •We will exclude ICUs that systematically apply checklists in the multiprofessional daily visit. We define systematically applied checklist when all the following criteria are met:
  • •Content: structured evaluation following a digital or printed document of multiple items focused on prevention of common ICU complications (eg. ventilator-associated pneumonia, stress ulcer, venous thromboembolism and/or catheter-associated bloodstream infection) and/or explicit assessment of daily goals;
  • •Time frame: daily application of checklist for at least 30 days
  • •Periodicity: at least 3 days per week
  • •How is applied: verbal, observational (1 professional check all items), with or without written register
  • •Patient inclusion criteria:
  • •Adult patients (≥18 years-old) with anticipated ICU length of stay > 24 hours.
  • •Patient exclusion criteria;
  • •High probability of death within 24 hours or patients admitted in ICU for palliative care only;
  • •Suspected or confirmed brain death.

Arms & Interventions

Daily checklist and clinician prompting

Experimental

Checklist during multidisciplinary daily visits + clinician prompting + audit & feedback

Intervention: Daily checklist and clinician prompting (Behavioral)

Usual care

No Intervention

Usual care

Outcomes

Primary Outcomes

In-hospital mortality truncated at 60 days

Time Frame: Hospital discharge; average of 20 days; follow-up limited to 60 days

Follow-up will be limited to 60 days after ICU admission. Patients who are still in the hospital after 60 days of ICU admission will be considered as discharged alive.

Secondary Outcomes

  • Head of the bed elevated at 30°(Every 3 three days, from ICU day 2 to 17)
  • Adequate prophylaxis for venous thromboembolism(Every 3 three days, from ICU day 2 to 17)
  • Patient-days under light sedation or alert and calm (RASS - 3 to 0)(Every 3 three days, from ICU day 2 to 17)
  • Rate of central-line catheter use(Daily from ICU day 2 to 17)
  • Indwelling urinary catheter use rate(Daily from ICU day 2 to 17)
  • Safety Attitudes Questionnaire Score(In phase 1, between sept/2013 and january/2014 each ICU staff answered the questionnaire once. In phase 2, between july/2014 and december/2014 the questionnaire was applied again (once for each ICU staff).)
  • ICU mortality(ICU discharge; follow-up limited to 60 days)
  • Central line-associated bloodstream infection (CLABSI) rate(Daily from ICU day 2 to 17)
  • Length of hospital stay(Hospital discharge; average of 20 days; follow-up limited to 60 days)
  • Mechanical ventilation-free days at 28 days(Day 28 after ICU admission)
  • Urinary tract infection associated with catheter rate(Daily from ICU day 2 to 17)
  • Ventilator-associated pneumonia (VAP)(Daily from ICU day 2 to 17)
  • Length of ICU stay(Hospital discharge; follow-up limited to 60 days)
  • Rate of patients receiving enteral or parenteral feeding(Every 3 three days, from ICU day 2 to 17)
  • Tidal volume <=8mL/kg of predicted body weight in patients on mechanical(Every 3 three days, from ICU day 2 to 17)

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials